Lundbeck

PsychoGenics is a preclinical Contract Research Organization (CRO) based in Paramus, NJ, specializing in central nervous system (CNS) and orphan disorders. With over 20 years of experience, the company offers validated disease models and comprehensive preclinical capabilities aimed at accelerating drug discovery for various therapeutic areas, including neurodegenerative and neurodevelopmental disorders. Renowned for its cutting-edge translational approach and custom solutions, PsychoGenics supports clients in quantifying treatment efficacy through a range of innovative services, such as behavioral testing, electrophysiology, and biomarker analysis. The firm boasts a robust portfolio of validated mouse models and advanced AI platforms, facilitating significant advancements in neuropsychiatric drug discovery. Generated from the website